Alcohol may amplify chronic rejection in lung transplantsNovember 28, 2007A recent study using an animal model of lung transplants shows that chronic alcohol consumption by the donor promotes scarring and airway injury after transplantation. The results raise questions about human lung donors with a history of alcohol abuse, say authors Patrick Mitchell, PhD, a postdoctoral researcher, and David Guidot, MD, professor of medicine at Emory University School of Medicine and director of the Emory Alcohol and Lung Biology Center. The study will be published in the Dec. 1 issue of the American Journal of Respiratory and Critical Care Medicine. Its findings have prompted doctors at Emory to begin a clinical study of the post-transplant effects of alcohol use among lung donors. "There are reasons to be concerned that chronic alcohol abuse by donors could increase the risk of complications in the transplanted lung," Dr. Guidot says. "Our goal is not to exclude donors, which would be the worst case scenario. Rather, it is to understand the biology, so that we can know how to intervene and make outcomes better." Dr. Mitchell, who designed the animal experiments, says that the team's long-term goals are to develop biological tests to measure the effects of alcohol on the lung and ways to compensate for those effects. About a sixth of deceased organ donors have a history of heavy alcohol consumption, defined as two or more drinks per day, according to the United Network for Organ Sharing (UNOS) database. That's more than triple the rate in the general population. Previous studies have shown that donor alcohol abuse increases the risk of heart failure after heart transplantation. But so far, clinical data describing the effect of alcohol abuse on lung transplants has been scarce. "There is considerable evidence that alcohol abuse increases the risk for lung disease and lung injury," Dr. Guidot says. "So it is a natural progression to look at lung transplants." In lung transplantation, chronic rejection comes in the form of obliterative bronchiolitis, a slow destruction of the lung followed by remodeling of the lung into scar tissue and irreversible airflow limitation. "Chronic rejection remains the major barrier to successful lung transplantation and unfortunately, suppressing the immune system doesn't change the outcome," he says. Lung transplantation treats the end stage of several diseases, including emphysema and cystic fibrosis. About 1,000 patients receive lung transplants annually in the United States and are chosen from a waiting list of around 4,000. Because of the lack of suitable donors, hundreds of people die annually waiting for a transplant. Although almost three-quarters of lung transplant recipients survive the first year after surgery, obliterative bronchiolitis affects the majority after five years, Dr. Guidot says. To examine the effects of alcohol on lung transplantation, the researchers used a model in which they transplanted a trachea from one strain of rat to another. Feeding alcohol for eight weeks to rats that became tracheal donors increased the degree to which scar tissue overran the transplants, the study shows. The "alcoholic" rats consumed 36 percent of their calories in alcohol. Donor alcohol consumption did not worsen chronic rejection in transplants within an inbred rat strain, but it did add to the incompatibility between the immune systems of rats from an "outbred" strain of rat that is less uniform genetically. Alcohol appeared to depress the number of white blood cells in the donor trachea pre-transplant but increased the production of growth factors that promote the expansion of scar tissue. Monitoring alcohol's effects of acute and chronic graft rejection after lung transplantation in humans is the next logical step, the Emory doctors say. Andres Pelaez, MD, a pulmonary medicine specialist at Emory's McKelvey Lung Transplant Center, will study lung transplant patients for a minimum of two years' observation. In parallel, his team will examine the prevalence of alcohol abuse in the potential donor pool, he says. "This study is uniquely poised to gather new information important for lung transplantation," Dr. Pelaez says. Emory University |
|||||||||||||||||||||
| Related Lung Transplant Current Events and Lung Transplant News Articles Test helps in fight against lung infections and for treating other life-threatening infections A new test developed by Edmonton-based Innovotech™ Inc. will now allow doctors to more accurately identify the right antibiotics required to treat serious, chronic infections that are biofilm based. Pitt team first to profile genes in acutely ill idiopathic pulmonary fibrosis patients The first findings from a one-of-a-kind, patient-driven effort to provide lung tissue for research might help doctors predict when patients with idiopathic pulmonary fibrosis (IPF) are becoming dangerously ill and also could point the way to interventions that could sustain them until life-saving transplants can be performed. Women with cystic fibrosis can have safe and successful fertility treatment Women with cystic fibrosis can have fertility treatment to help them have babies without any long-term adverse effects on either themselves or their children. Gene therapy technique thwarts cancer by cutting off tumor blood supply University of Florida researchers have come up with a new gene therapy method to disrupt cancer growth by using a synthetic protein to induce blood clotting that cuts off a tumor's blood and nutrient supply. Protein may be strongest indicator of rare lung disease, study shows Researchers at the University of Cincinnati (UC) have discovered a protein in the lungs that can help in determining progression of the rare lung disease Idiopathic Pulmonary Fibrosis (IPF). Breathing life into injured lungs: World-first technique will expand lung donor organ pool For the first time in the world, transplant surgeons at Toronto General Hospital, University Health Network used a new technique to repair an injured donor lung that was unsuitable for transplant, and then successfully transplanted it into a patient. New clinical trial for patients with asbestos-associated lung cancer The Mesothelioma Center within the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital and Columbia University Medical Center is now recruiting patients for a clinical research study of a new targeted radiation and chemotherapy protocol for pleural mesothelioma, a cancer of the lung's lining that is almost always caused by previous exposure to asbestos. Depression and PTSD symptoms in caregivers of lung transplant patients Symptoms of depression and post-traumatic stress disorder (PTSD) among caregivers of deceased lung transplant patients are four-to-five times more prevalent than in the average population, according to researchers who analyzed the stress levels of caregivers, as well as their perceptions of the transplant recipients' quality of dying and death. UCSF marks a milestone with 500th transplant in heart and lung program UCSF marked a milestone this week with the 500th procedure in its Thoracic Transplant Program, which specializes in transplantation of the heart and lung. Lung transplants in cystic fibrosis patients with life-threatening bacteria sparks debate at ISHLT During Wednesday's Satellite Symposium 3: The Challenges of Lung Transplantation in Cystic Fibrosis (CF) at the International Society of Heart and Lung Transplantation (ISHLT) Annual Meeting & Scientific Sessions, clinicians and researchers discussed some of the unique challenges in achieving excellent lung transplant outcomes in patients with CF. More Lung Transplant Current Events and Lung Transplant News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||